Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Long MRNA ETF

97.06
+13.8116.59%
Post-market: 97.520.4600+0.47%19:06 EDT
Volume:520.76K
Turnover:50.27M
Market Cap:27.18M
PE:- -
High:101.81
Open:91.36
Low:88.02
Close:83.25
52wk High:143.84
52wk Low:14.95
Shares:280.00K
Float Shares:280.00K
Volume Ratio:3.01
T/O Rate:185.99%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Review & Preview: Risky Business

Dow Jones
·
Aug 26

Moderna (MRNA) Is Up 151.8% After First Positive Phase 3 mRNA Cancer Therapy Result - What's Changed

Simply Wall St.
·
Aug 26

Trading DAY-Oil, Yields Slide

Reuters
·
Aug 26

Moderna Inc. Stock Rallies 14.4%, Outperforms Peers

Dow Jones
·
Aug 26

S&P 500 Top and Bottom Performing Stocks at About 03:30 P.m. EDT

Reuters
·
Aug 26

Moderna Shares Rise After Wolfe Research Upgrade

MT Newswires Live
·
Aug 26

Moderna Stock Gains as Melanoma Vaccine Results De-Risk Approach

Dow Jones
·
Aug 26

Moderna rises 13.0%

TIPRANKS
·
Aug 26

Moderna Stock (MRNA) Rises 12.5% Today Following Phase 3 mRNA Cancer Vaccine Win with Merck

TIPRANKS
·
Aug 26

Top Calls On Wall Street: Nvidia, AMD, SpaceX, Netflix, Dell, Coinbase, Moderna, Strategy, and More

Tiger Newspress
·
Aug 25

Moderately bullish activity in Moderna with shares up 11.44%

TIPRANKS
·
Aug 25

BeOne announces FDA approval for Tevimbra-based reginmen for HER2+ GEA

TIPRANKS
·
Aug 25

Moderna Raised to Peer Perform from Underperform by Wolfe Research

Dow Jones
·
Aug 25

What Happens if Moderna's Cancer Vaccine Works

Dow Jones
·
Aug 25

Market Movers | Bloom Energy Rises on Pelosi Buy; Nebius, NetEase Gain on Goldman Calls; Moderna Rallies

Tiger Newspress
·
Aug 25

Moderna Inc Stock (MRNA) Moved Up by 10.02% on Aug 25: Drivers Behind the Movement

TradingKey
·
Aug 25

Moderna on Track for Best Month on Record

Dow Jones
·
Aug 25

Early notable gainers among liquid option names on August 25th

TIPRANKS
·
Aug 25

Moderna Shares up 8.4% as Barclays Hikes Price Target

THOMSON REUTERS
·
Aug 25

After Moderna’s $44B Oncology Win, Silexion’s Pancreatic Cancer Treatment is Worth Exploring (NASDAQ: SLXN)

TIPRANKS
·
Aug 25